Skip to content

Study for the safety of oral asiaticoside tablets in climbing and the clinical trial of exploratory treatment of keloid

Study for the safety of oral asiaticoside tablets in climbing and the clinical trial of exploratory treatment of keloid

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033631
Enrollment
Unknown
Registered
2020-06-07
Start date
2020-06-30
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid

Interventions

Sponsors

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with keloid aged 20-70 years old; 2. The patients with large keloid area (> 3x3 cm2), wide keloid (length > 4cm) and wide keloid (number > 3) could not be improved by operation or local injection; 3. The patients who sign the informed consent voluntarily after knowing the treatment plan and risks are willing to accept the clinical trial and cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or women with pregnancy planning; 2. Patients with wound or epidermis breaking in the focus area; 3. Patients with local small keloid; 4. Patients who do not accept the study management method; 5. Patients who are participating in other clinical trials; 6. Patients with serious basic diseases or mental and psychological disorders.

Design outcomes

Primary

MeasureTime frame
pharmacokinetic data;

Countries

China

Contacts

Public ContactLiu Wei

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

liuwei_md@126.com+86 13641957463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026